Decreasing production of the organ-damaging<unk>  chains is the treatment goal. Options include chemotherapy using bortezomib, autologous stem cell transplantation, immunomodulatory drugs, and kidney transplant.There is no standard treatment for<unk> . High-dose melphalan in conjunction with autologous stem cell transplantation has been used in some patients. A regimen of bortezomib and dexamethasone has also been examined.
Light chain deposition disease
Heavy chain disease
AL amyloidosis
Familial renal amyloidosis
AA amyloidosis
IgG4-related disease
Thin basement membrane disease
HIV-associated nephropathy